Literature DB >> 1655206

Mucosal dysplasia of the liver and the intraductal variant of peripheral cholangiocarcinoma in hepatolithiasis.

T Ohta1, T Nagakawa, N Ueda, T Nakamura, T Akiyama, K Ueno, I Miyazaki.   

Abstract

Four cases are reported of the intraductal variant of peripheral cholangiocarcinoma among surgical specimens from 32 cases of hepatolithiasis. The cancers arose from the periphery of the stone-containing bile duct and spread chiefly along the luminal surface. Microscopically, these tumors showed papillary proliferation and therefore were diagnosed as the intraductal spreading type of peripheral cholangiocarcinoma. Mucosal dysplasia also was noticed in the vicinity of the tumors. In six other cases, mucosal dysplasia was observed in the periphery of the stone. Immunohistochemically, anti-CA 19-9 staining was observed diffusely in the cytoplasm of dysplastic lesions and carcinomas. Anti-carcinoembryonic antigen staining was restricted to the luminal surface and/or the supranuclear region of the cytoplasm in carcinomas. It was not identified in dysplastic cells. These results suggest that the mucosal dysplasia occasionally observed near stones is a precursor of the intraductal spreading type of peripheral cholangiocarcinoma in the presence of hepatolithiasis. The authors hypothesize that the lining epithelium of the large bile duct, when persistently exposed to biochemically altered bile, may undergo a carcinomatous transformation through a stage of mucosal dysplasia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1655206     DOI: 10.1002/1097-0142(19911115)68:10<2217::aid-cncr2820681021>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Risk Factors for Cholangiocarcinoma After Initial Hepatectomy for Intrahepatic Stones.

Authors:  Ze-Wu Meng; Sheng-Hua Han; Jin-Hai Zhu; Liang-Yi Zhou; Yan-Ling Chen
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

2.  Incidence and Prognosis of Subsequent Cholangiocarcinoma in Patients with Hepatic Resection for Bile Duct Stones.

Authors:  Hyun Jung Kim; Tae Uk Kang; Heather Swan; Min Ji Kang; Nayoung Kim; Hyeong Sik Ahn; Seon Mee Park
Journal:  Dig Dis Sci       Date:  2018-08-31       Impact factor: 3.199

3.  Late development of bile duct cancer in patients who had biliary-enteric drainage for benign disease: a follow-up study of more than 1,000 patients.

Authors:  A Tocchi; G Mazzoni; G Liotta; L Lepre; D Cassini; M Miccini
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

4.  Intraductal papillary neoplasm of the bile duct in liver cirrhosis with hepatocellular carcinoma.

Authors:  Jing Xu; Yasunori Sato; Kenichi Harada; Norihide Yoneda; Teruyuki Ueda; Atsushi Kawashima; Yasunin Nakanuma
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

Review 5.  Clonorchiasis and cholangiocarcinoma: etiologic relationship and imaging diagnosis.

Authors:  Byung Ihn Choi; Joon Koo Han; Sung Tae Hong; Kyoung Ho Lee
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

6.  Cholangiocarcinoma arising in bile duct adenoma with focal area of bile duct hamartoma.

Authors:  T Hasebe; M Sakamoto; K Mukai; N Kawano; M Konishi; M Ryu; S Fukamachi; S Hirohashi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

7.  Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China.

Authors:  Yan-Ming Zhou; Zheng-Feng Yin; Jia-Mei Yang; Bin Li; Wen-Yu Shao; Feng Xu; Yu-Lan Wang; Dian-Qi Li
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

8.  A proposed severity classification system for hepatolithiasis based on an analysis of prognostic factors in a Japanese patient cohort.

Authors:  Yutaka Suzuki; Toshiyuki Mori; Masaaki Yokoyama; Sangchul Kim; Hirokazu Momose; Ryota Matsuki; Masaharu Kogure; Nobutsugu Abe; Hiroyuki Isayama; Takahiro Nakazawa; Kenji Notohara; Atsushi Tanaka; Toshio Tsuyuguchi; Susumu Tazuma; Hajime Takikawa; Masanori Sugiyama
Journal:  J Gastroenterol       Date:  2017-11-08       Impact factor: 7.527

9.  Gross pathological classification of peripheral cholangiocarcinoma determines the efficacy of hepatectomy.

Authors:  Chun-Nan Yeh; Ta-Sen Yeh; Tse-Ching Chen; Yi-Yin Jan; Miin-Fu Chen
Journal:  J Gastroenterol       Date:  2012-09-25       Impact factor: 7.527

10.  High serum CA19-9 levels are associated with an increased risk of cholangiocarcinoma in patients with intrahepatic duct stones: a case-control study.

Authors:  Jung Hyun Jo; Moon Jae Chung; Jeong Youp Park; Seungmin Bang; Seung Woo Park; Kyung Sik Kim; Woo Jung Lee; Si Young Song; Jae Bock Chung
Journal:  Surg Endosc       Date:  2013-06-13       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.